Ten‐Year Pediatric Heart Transplantation: Insights and Outcomes From a Leading Center in Iran
Pediatric heart transplant outcomes have improved over the past decade, although challenges remain. Significant risk factors for mortality include donor age, male donor gender, and 28 Rituximab treatment. Strategies to mitigate these risks could enhance survival rates post-transplant.
Authors
- Alireza Yaghoubi
- Mohammad Mahdavi (ORCID: https://orcid.org/0000-0002-2883-2736)
- Ali Sadeghpour Tabaei (ORCID: https://orcid.org/0000-0002-9359-421X)
- Amirhosein Jalali
- Abbas Pousti
- Maziar Gholampour Dehaki (ORCID: https://orcid.org/0000-0003-4293-7398)
- Hasan Tatari (ORCID: https://orcid.org/0000-0002-3343-8581)
- Mohammad Zia Totonchi
- Zahra Ansari Aval (ORCID: https://orcid.org/0000-0001-5019-2563)
- Golnar Mortaz Hejri (ORCID: https://orcid.org/0000-0002-7739-5739)
- Hossein Shahzadi
- Yaser Tolouei Tabar
- Hossein Mehrali
Institutions
- Iran University of Medical Sciences (IR)
- Shaheed Rajaei Cardiovascular Medical and Research Center (IR)
Publication Details
- Journal
- Pediatric Transplantation
- Published
- 2025-04-18
- DOI
- https://doi.org/10.1111/petr.70081
- Citations
- 1
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.01